ATE77754T1 - Zusammensetzungen zur behandlung von gehirntumoren. - Google Patents
Zusammensetzungen zur behandlung von gehirntumoren.Info
- Publication number
- ATE77754T1 ATE77754T1 AT89301258T AT89301258T ATE77754T1 AT E77754 T1 ATE77754 T1 AT E77754T1 AT 89301258 T AT89301258 T AT 89301258T AT 89301258 T AT89301258 T AT 89301258T AT E77754 T1 ATE77754 T1 AT E77754T1
- Authority
- AT
- Austria
- Prior art keywords
- drug
- migration
- administration
- compositions
- treatment
- Prior art date
Links
- 208000003174 Brain Neoplasms Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 3
- 229940079593 drug Drugs 0.000 abstract 3
- 230000002159 abnormal effect Effects 0.000 abstract 2
- 230000001413 cellular effect Effects 0.000 abstract 2
- 239000011159 matrix material Substances 0.000 abstract 2
- 230000005012 migration Effects 0.000 abstract 2
- 238000013508 migration Methods 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 229940122803 Vinca alkaloid Drugs 0.000 abstract 1
- 229940127089 cytotoxic agent Drugs 0.000 abstract 1
- 239000002254 cytotoxic agent Substances 0.000 abstract 1
- 230000009969 flowable effect Effects 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 238000007917 intracranial administration Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000006461 physiological response Effects 0.000 abstract 1
- 230000009290 primary effect Effects 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Fertilizers (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15498488A | 1988-02-11 | 1988-02-11 | |
| EP89301258A EP0328389B1 (de) | 1988-02-11 | 1989-02-09 | Zusammensetzungen zur Behandlung von Gehirn-Tumoren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE77754T1 true ATE77754T1 (de) | 1992-07-15 |
Family
ID=22553654
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT89301258T ATE77754T1 (de) | 1988-02-11 | 1989-02-09 | Zusammensetzungen zur behandlung von gehirntumoren. |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0328389B1 (de) |
| JP (1) | JP2862175B2 (de) |
| AT (1) | ATE77754T1 (de) |
| CA (1) | CA1330422C (de) |
| DE (1) | DE68901931T2 (de) |
| ES (1) | ES2045404T3 (de) |
| GR (1) | GR3005841T3 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5626862A (en) | 1994-08-02 | 1997-05-06 | Massachusetts Institute Of Technology | Controlled local delivery of chemotherapeutic agents for treating solid tumors |
| US5750146A (en) * | 1995-04-28 | 1998-05-12 | Matrix Pharmaceutical, Inc. | Translucent collagen formulations with a cytotoxic drug |
| DE10037983B4 (de) * | 2000-08-03 | 2006-04-13 | Stefan Zikeli | Polymerzusammensetzung und daraus hergestellter Formkörper mit einem Gehalt an Alkaloid |
| JP2003119156A (ja) * | 2001-08-06 | 2003-04-23 | Kikuji Yamashita | コラーゲンを含有する口腔用剤、医薬品および医薬部外品 |
| CN1923281B (zh) * | 2005-08-30 | 2010-05-05 | 孔庆忠 | 一种含植物生物碱的抗癌缓释注射剂 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU179753B (en) * | 1977-10-13 | 1982-12-28 | Richter Gedeon Vegyeszet | Process for producting synergetic pharmaceutical compositions of citostatic activity |
| US4619913A (en) * | 1984-05-29 | 1986-10-28 | Matrix Pharmaceuticals, Inc. | Treatments employing drug-containing matrices for introduction into cellular lesion areas |
-
1989
- 1989-02-09 AT AT89301258T patent/ATE77754T1/de not_active IP Right Cessation
- 1989-02-09 ES ES89301258T patent/ES2045404T3/es not_active Expired - Lifetime
- 1989-02-09 DE DE8989301258T patent/DE68901931T2/de not_active Expired - Lifetime
- 1989-02-09 JP JP1028798A patent/JP2862175B2/ja not_active Expired - Fee Related
- 1989-02-09 EP EP89301258A patent/EP0328389B1/de not_active Expired - Lifetime
- 1989-02-10 CA CA000590770A patent/CA1330422C/en not_active Expired - Fee Related
-
1992
- 1992-09-30 GR GR920402175T patent/GR3005841T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GR3005841T3 (de) | 1993-06-07 |
| DE68901931T2 (de) | 1992-12-10 |
| EP0328389A2 (de) | 1989-08-16 |
| JPH021406A (ja) | 1990-01-05 |
| EP0328389B1 (de) | 1992-07-01 |
| DE68901931D1 (de) | 1992-08-06 |
| JP2862175B2 (ja) | 1999-02-24 |
| ES2045404T3 (es) | 1994-01-16 |
| EP0328389A3 (en) | 1989-10-11 |
| CA1330422C (en) | 1994-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69806246T3 (de) | Zusammensetzung enthaltend capsaicin oder seine analogen und lokalanästhetika | |
| KR100334051B1 (ko) | 탁산유도체를함유하는항종양조성물 | |
| EP1064000A4 (de) | Vitamin d und dessen analoge zur behandlung vom tumoren und anderen hyperproliferativen erkrankungen | |
| ATE399553T1 (de) | Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen | |
| ATE55258T1 (de) | Arzneimittelenthaltende matrizen fuer einfuehrungen in zonen mit cellularen lesionen. | |
| ES2058592T3 (es) | El uso de sustancias activas fisiologicamente para la fabricacion de medicamentos para enfermedades cerebrales y neuronales. | |
| DE69533112D1 (de) | Verwendung von flavolignanen zur herstellung von medikamenten mit antiproliferativer aktivität in gebärmutter,brust,eierstöcken | |
| DE69213814D1 (de) | Melatoninderivate zur Behandlung von Schlafstörungen und zur Pre-Anästhesie | |
| DE69430132D1 (de) | Pernasale zusammensetzung und diese enthaltende pernasale zubereitung | |
| DE3851776D1 (de) | Verwendung von IGF-II zur Behandlung von Knochenkrankheiten. | |
| ATE202709T1 (de) | Zusammensetzungen die g-csf und ein tnf- bindungsprotein enthalten | |
| BR9813318A (pt) | Processo de tratamento de tumores e degeneração macular em paciente humano ou veterinário, composição farmacêutica para tratamento de tumores e degeneração macular em um paciente humano ou veterinário | |
| ATE392901T1 (de) | Mucuna pruriens und extrakte daraus zur behandlung von neurologischen erkrankungen | |
| Friedman et al. | Chemotherapy of subcutaneous and intracranial human medulloblastoma xenografts in athymic nude mice | |
| ATE77754T1 (de) | Zusammensetzungen zur behandlung von gehirntumoren. | |
| Griffin et al. | Preferential action of arsenic trioxide in solid-tumor microenvironment enhances radiation therapy | |
| ATE334590T1 (de) | Anti-arrhythmische zusammensetzungen und behandlungsverfahren | |
| DE60221352T2 (de) | Zusammensetzung und kit zur verwendung in der tumorbehandlung | |
| Marlin et al. | Effect of the dural application of Zenker's solution on the feline brain | |
| AR006202A1 (es) | Usos de antagonista ige para preparar un medicamento util para el tratamiento de las enfermedades alergicas y composiciones que los contiene | |
| DE69314586D1 (de) | Arzneimittelzusammensetzung enthaltend TCF-II | |
| KR890000108A (ko) | 종양 치료용 약제학적 조성물 | |
| EA200400348A1 (ru) | Цисплатиновые составы пониженной токсичности и способы их применения | |
| WO2024081428A3 (en) | Selective modulators of ahr-regulated transcription and method for using such modulators to treat cancer | |
| Olds et al. | Effects of meprobamate, chlordiazepoxide, diazepam, and sodium pentobarbital on visually evoked responses in the tectotegmental area of the rat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |